Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telesis Bio, Inc. - Common Stock (NQ:TBIO)

3.230 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telesis Bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Telesis Bio to Present at Jefferies Healthcare Conference 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery 
From Telesis Bio
Via GlobeNewswire
Telesis Bio: Q1 Earnings Insights
 
Via Benzinga
Telesis Bio Earnings Perspective: Return On Capital Employed
 
Via Benzinga
A Preview Of Telesis Bio's Earnings
 
Via Benzinga
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
From Telesis Bio
Via GlobeNewswire
Telesis Bio Secures Financing of $28.0 Million
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at SynBioBeta 2023
Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
Showcasing Automated Molecular Biology Workstation for Synthetic Biology and Genomics Applications 
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Telesis Bio Reports First Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
From Telesis Bio
Via GlobeNewswire
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation 
From Telesis Bio
Via GlobeNewswire
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning! 
Via InvestorPlace
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
From Telesis Bio
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
Telesis Bio to Present at Festival of Biologics Conference
Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions” 
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
From Telesis Bio
Via GlobeNewswire
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA 
From Telesis Bio
Via GlobeNewswire
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.